CN101538266B - 罗格列酮半抗原、人工抗原和抗体及其制备方法和应用 - Google Patents
罗格列酮半抗原、人工抗原和抗体及其制备方法和应用 Download PDFInfo
- Publication number
- CN101538266B CN101538266B CN2009100390209A CN200910039020A CN101538266B CN 101538266 B CN101538266 B CN 101538266B CN 2009100390209 A CN2009100390209 A CN 2009100390209A CN 200910039020 A CN200910039020 A CN 200910039020A CN 101538266 B CN101538266 B CN 101538266B
- Authority
- CN
- China
- Prior art keywords
- rosiglitazone
- antibody
- artificial antigen
- rogridone
- haptens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 63
- 102000036639 antigens Human genes 0.000 title claims abstract description 63
- 108091007433 antigens Proteins 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 claims abstract description 36
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 claims description 248
- 229960004586 rosiglitazone Drugs 0.000 claims description 124
- 238000006243 chemical reaction Methods 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 28
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 26
- 102000014914 Carrier Proteins Human genes 0.000 claims description 20
- 108010078791 Carrier Proteins Proteins 0.000 claims description 20
- 238000000502 dialysis Methods 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 16
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 229940098773 bovine serum albumin Drugs 0.000 claims description 15
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 15
- 108010058846 Ovalbumin Proteins 0.000 claims description 12
- 229940092253 ovalbumin Drugs 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 150000008064 anhydrides Chemical class 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 238000012856 packing Methods 0.000 claims description 10
- 239000011734 sodium Substances 0.000 claims description 10
- 102000009843 Thyroglobulin Human genes 0.000 claims description 9
- 108010034949 Thyroglobulin Proteins 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 9
- 229960002175 thyroglobulin Drugs 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 7
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 7
- 235000015320 potassium carbonate Nutrition 0.000 claims description 7
- 239000000872 buffer Substances 0.000 claims description 6
- 125000001475 halogen functional group Chemical group 0.000 claims description 6
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 235000007715 potassium iodide Nutrition 0.000 claims description 5
- 229960004839 potassium iodide Drugs 0.000 claims description 5
- 230000001681 protective effect Effects 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- 239000000741 silica gel Substances 0.000 claims description 5
- 229910002027 silica gel Inorganic materials 0.000 claims description 5
- 229960001866 silicon dioxide Drugs 0.000 claims description 5
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 claims description 5
- 108010062580 Concanavalin A Proteins 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 108060003552 hemocyanin Proteins 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 108060003951 Immunoglobulin Proteins 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 2
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 2
- 230000028993 immune response Effects 0.000 claims description 2
- 102000018358 immunoglobulin Human genes 0.000 claims description 2
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 claims 1
- 230000008878 coupling Effects 0.000 abstract description 13
- 238000010168 coupling process Methods 0.000 abstract description 13
- 238000005859 coupling reaction Methods 0.000 abstract description 13
- 238000001514 detection method Methods 0.000 abstract description 12
- 108090000623 proteins and genes Proteins 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 241001465754 Metazoa Species 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 150000008065 acid anhydrides Chemical class 0.000 abstract 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical class C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 abstract 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 15
- 230000003053 immunization Effects 0.000 description 14
- 230000036039 immunity Effects 0.000 description 9
- 238000002649 immunization Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000013016 damping Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 102000000536 PPAR gamma Human genes 0.000 description 3
- 108010016731 PPAR gamma Proteins 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000013019 agitation Methods 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 238000002798 spectrophotometry method Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000283977 Oryctolagus Species 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 229940027941 immunoglobulin g Drugs 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 101710153593 Albumin A Proteins 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- PQOHQGYFFDPXTQ-UHFFFAOYSA-N C(CCCCCC)(=O)O.[Cl] Chemical compound C(CCCCCC)(=O)O.[Cl] PQOHQGYFFDPXTQ-UHFFFAOYSA-N 0.000 description 1
- -1 CONA Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229940123464 Thiazolidinedione Drugs 0.000 description 1
- QKRAOTCLMXZGQF-UHFFFAOYSA-N [Na].BrCC(=O)O Chemical compound [Na].BrCC(=O)O QKRAOTCLMXZGQF-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 229940062310 avandia Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 230000024835 cytogamy Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- SUFUKZSWUHZXAV-BTJKTKAUSA-N rosiglitazone maleate Chemical compound [H+].[H+].[O-]C(=O)\C=C/C([O-])=O.C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O SUFUKZSWUHZXAV-BTJKTKAUSA-N 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 150000003384 small molecules Chemical group 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000001467 thiazolidinediones Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000004454 trace mineral analysis Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
Description
抗原浓度 | 抗体倍数 | 检测时间 | 检测温度 | 线性范围 | 检测限 |
100ng/ml | 一抗:1/20000二抗:1/10000 | 一抗:1min二抗:1h | 37℃ | 7.5~1740.0ng/ml | 1.5ng/ml |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100390209A CN101538266B (zh) | 2009-04-27 | 2009-04-27 | 罗格列酮半抗原、人工抗原和抗体及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100390209A CN101538266B (zh) | 2009-04-27 | 2009-04-27 | 罗格列酮半抗原、人工抗原和抗体及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101538266A CN101538266A (zh) | 2009-09-23 |
CN101538266B true CN101538266B (zh) | 2011-06-22 |
Family
ID=41121678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100390209A Expired - Fee Related CN101538266B (zh) | 2009-04-27 | 2009-04-27 | 罗格列酮半抗原、人工抗原和抗体及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101538266B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102516148B (zh) * | 2011-11-23 | 2013-09-11 | 华南农业大学 | 细交链孢菌酮酸的半抗原和抗原及其制备方法与应用 |
CN105277685A (zh) * | 2014-07-25 | 2016-01-27 | 江苏维赛科技生物发展有限公司 | 一种检测噻唑烷酮类的试剂盒的制备及其检测方法 |
CN105622505A (zh) * | 2016-01-04 | 2016-06-01 | 河北北方学院 | 一种丙酸环丙沙星抗原的合成 |
CN107098961A (zh) * | 2017-06-14 | 2017-08-29 | 重庆师范大学 | 雷公藤甲素人工抗原及制备方法和多克隆抗体 |
CN109706124A (zh) * | 2019-01-09 | 2019-05-03 | 江南大学 | 一株罗格列酮单克隆抗体杂交瘤细胞株及其应用 |
CN110330488A (zh) * | 2019-06-20 | 2019-10-15 | 深圳市易瑞生物技术股份有限公司 | 一种吡罗昔康半抗原及其制备方法和应用 |
CN110412284B (zh) * | 2019-07-03 | 2024-05-24 | 广东省食品检验所(广东省酒类检测中心) | 一种吡格列酮检测装置及其应用 |
-
2009
- 2009-04-27 CN CN2009100390209A patent/CN101538266B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101538266A (zh) | 2009-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101538266B (zh) | 罗格列酮半抗原、人工抗原和抗体及其制备方法和应用 | |
CN101113981A (zh) | 磺胺类药物直接竞争酶联免疫检测试剂盒 | |
CN104017070B (zh) | 一种高灵敏度的多菌灵完全抗原的合成方法 | |
AU2007257105A1 (en) | Elisa kit for detecting Sudan red and method thereof | |
CN102917592A (zh) | 利培酮免疫测定 | |
CN101256188A (zh) | 检测林可霉素药物的酶联免疫试剂盒及其应用 | |
CN101863981A (zh) | 一种抗双酚a单克隆抗体的制备方法 | |
CN103575889B (zh) | 一种检测万古霉素的试纸条及方法 | |
CN101571539A (zh) | 检测头孢类药物的酶联免疫试剂盒及其应用 | |
CN101538307B (zh) | 去氢表雄酮半抗原、人工抗原和抗体及其制备方法和应用 | |
CN101962358A (zh) | 环丙沙星半抗原、人工抗原和抗体及其制备方法和应用 | |
CN101776685B (zh) | 检测三甲氧苄胺嘧啶药物的酶联免疫试剂盒及其应用 | |
CN106645760B (zh) | 一种去氢甲睾酮抗原及其制备方法和检测试纸卡 | |
CN102827076A (zh) | 一种氟喹诺酮类药物通用半抗原、人工抗原、广谱单克隆抗体及其制备方法与应用 | |
CN106866568A (zh) | 呋喃唑酮代谢物aoz衍生化半抗原、人工抗原的制备方法及其应用 | |
CN110713986B (zh) | 一株维生素b1单克隆抗体杂交瘤细胞株cbdd及其应用 | |
CN101403752A (zh) | 一种加替沙星的化学发光酶联免疫检测试剂盒 | |
CN102875671A (zh) | 噻虫胺抗原、抗体及其应用 | |
CN109265404A (zh) | 一种多菌灵半抗原与抗原的制备方法及应用 | |
CN106831498B (zh) | 呋喃西林代谢物sem衍生化半抗原、人工抗原的制备方法及其应用 | |
CN106366193A (zh) | 一种以胆酸为原料制备甘氨胆酸多克隆抗体的方法 | |
CN102336831A (zh) | 一种抗西地那非的特异性抗体 | |
CN1904613B (zh) | 用于磺胺类多种残留免疫分析的人工抗原的制备方法 | |
CN107677807A (zh) | 一种吉他霉素磁免疫化学发光检测试剂盒 | |
CN104109112A (zh) | 赛庚啶半抗原、人工抗原和抗体及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170522 Address after: 510642, Guangzhou, Guangdong 483 Tianhe District five mountain road, South China Agricultural University veterinary science and technology building on the third floor Patentee after: Guangdong Nongda Assets Management Co.,Ltd. Address before: 510642 Tianhe District, Guangdong, No. five road, No. 483, Patentee before: South China Agricultural University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200520 Address after: Room 601, 6th floor, industrial innovation center, No.1 Chaozhong Industrial Innovation Park, Dongshan Road senior technical school, Chaozhou City, Guangdong Province Patentee after: Huanong (Chaozhou) Food Research Institute Co.,Ltd. Address before: 510642, Guangzhou, Guangdong 483 Tianhe District five mountain road, South China Agricultural University veterinary science and technology building on the third floor Patentee before: Guangdong Nongda Assets Management Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110622 |